Epidermal growth factor receptor mutations predict sensitivity to gefitinib in patients with non-small-cell lung cancer

By Riedel Richard F   Febbo Phillip G  

Future Oncology, Vol. 1, Iss. 4, 2005-08 ,pp. : 461-466

Future Medicine

Access to resources Recommend Favorite

Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer

By Sasaki Hidefumi   Endo Katsuhiko   Okuda Katsuhiro   Kawano Osamu   Kitahara Naoto   Tanaka Hisaichi   Matsumura Akihide   Iuchi Keiji   Takada Minoru   Kawahara Masaaki   Kawaguchi Tomoya   Yukiue Haruhiro   Yokoyama Tomoki   Yano Motoki   Fujii Yoshitaka  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 5, 2008-05 ,pp. : 569-577

Springer Publishing Company

Access to resources Recommend Favorite

The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients

By Sun Jong-Mu   Won Young-Woong   Kim Seung   Kim Jung   Choi Yoon-La   Lee Jeeyun   Park Yeon   Ahn Jin   Park Keunchil   Ahn Myung-Ju  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 4, 2011-04 ,pp. : 687-694

Springer Publishing Company

Access to resources Recommend Favorite

A new rapid method for detecting epidermal growth factor receptor mutations in non-small cell lung cancer

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1040-1048

Spandidos Publications

Access to resources Recommend Favorite

Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung

By Rahman Shakibur   Kondo Nobuyuki   Yoneda Kazue   Takuwa Teruhisa   Hashimoto Masaki   Orui Hayato   Okumura Yoshitomo   Tanaka Fumihiro   Kumamoto Kanako   Mostafa Mohammad   Chowdhury Golam   Haque Akramul   Hasegawa Seiki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 45-49

Springer Publishing Company

Access to resources Recommend Favorite